Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 1, 2010, Pages 52-55

  Morishima, Manabu ^a   Marui, Akira ^a   Yanagi, Shigeki ^a   Nomura, Takamasa ^a   Nakajima, Naoki ^b   Hyon, Suong Hyu ^b   Ikeda, Tadashi ^a   Sakata, Ryuzo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Antibiotics; Glue; Infection; Prosthesis

Indexed keywords

GLUE; VANCOMYCIN; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; POLYETHYLENE TEREPHTHALATE; TISSUE ADHESIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; CELL DENSITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG TISSUE LEVEL; GRAFT INFECTION; HYDROGEL; INFECTION PREVENTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; RAT; SUSTAINED DRUG RELEASE; ANIMAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; DELAYED RELEASE FORMULATION; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROSTHESIS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COLONY COUNT, MICROBIAL; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; POLYETHYLENE TEREPHTHALATES; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; TISSUE ADHESIVES; TISSUE DISTRIBUTION; VANCOMYCIN;

EID: 77954549032     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.232447     Document Type: Article

References (14)

1. Kitamura T, Morota T, Motomura N, Ono M, Shibata K, Ueno K, Kotsuka Y, Takamoto S. Management of infected grafts and aneurysms of the aorta. Ann Vase Surg 2005;19:335-342.
2. Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vase Surg 2007;46:148-155.
3. Murphy GJ, Pararajasingam R, Nasim A, Dennis MJ, Sayers RD. Methicil-lin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl 2001;83:158-163.
4. Nasim A, Thompson MM, Naylor AR, Bell PR, London NJ. The impact of MRSA on vascular surgery. Eur J Vase Endovasc Surg 2001;22:211-214.
5. Hirose K, Marui A, Arai Y, Nomura T, Inoue S, Kaneda K, Kamitani T, Fujita M, Mitsuyama M, Tabata Y, Komeda M. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. J Vase Surg 2006;44:377-382.
6. Sakaguchi H, Marui A, Hirose K, Nomura T, Arai Y, Bir SC, Huang Y, Esaki J, Tabata Y, Ikeda T, Komeda M. Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin. J Thorac Cardiovasc Surg 2008;135:25-31.
7. Nakajima N, Sugai H, Tsutsumi S, Hyon SH. Self-degradable bioadhesive. Key Eng Mat 2007;342-343:713-716.
8. Araki M, Tao H, Nakajima N, Sugai H, Sato T, Hyon SH, Nagayasu T, Nakamura T. Development of new biodegradable hydrogel glue for preventing alveolar air leakage. J Thorac Cardiovasc Surg 2007; 134: 1241-1248.
9. Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D'Amato G, Balaban N, Saba V, Scalise G. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopep-tides. Circulation 2003;108:767-771.
10. Fujimoto K, Yamamura K, Osada T, Hayashi T, Nabeshima T, Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier. J Biomed Mater Res 1997;36:564-567.
11. Muhl E, Gatermann S, Iven H, Dendorfer A, Bruch HP. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model. Ann Vase Surg 1996;10:244-253.
12. Sacar M, Sacar S, Kaleli I, Onem G, Turgut H, Goksin I, Ozcan V, Kaan Inan B, Duver H, Baltalarli A. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J Surg Res 2007;139:170-175.
13. Koshiko S, Sasajima T, Muraki S, Azuma N, Yamazaki K, Chiba K, Tachibana M, Inaba M. Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vase Surg 2002;35:779-785.
14. Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group. Br J Surg 1998; 85:1378-1381.